Skip to main content

Table 3 Factors related to ECG abnormalities in patients with cirrhosis at pre-transplant evaluation in multivariate logistic regression analysis (n = 186)

From: Prevalence of pre-transplant electrocardiographic abnormalities and post-transplant cardiac events in patients with liver cirrhosis

ECG abnormality

Factor

Odds ratio (95% confidence interval)

Prolonged QTc time

Possible QT prolonging drug1

5.84 (1.87-18.22)

Alcoholic cirrhosis

2.99 (1.25-7.18)

Age (years)

1.06 (1.01-1.10)

Mean arterial pressure

0.94 (0.90-.0.97)

Propranolol

0.25 (0.1-0.65)

Q wave

MELD score (per 1 unit)

1.08 (1.02–1.16)

Age (per year)

1.12 (1.04-1.20)

QRS axis deviation

History of arterial hypertension (if yes)

3.14 (1.16-8.47)

Male sex (if yes)

4.40 (1.25-15.43)

ST-segment depression

History of arterial hypertension (if yes)

7.00 (1.30-37.84)

Cholestatic liver disease (if yes)

6.10 (1.24-30.15)

Any feature of CAD 2

MELD score (per 1 unit)

1.08 (1.02-1.14)

Age (per year)

1.05 (1.01-1.09)

Viral liver disease (if yes)

0.26 (0.08-0.84)

  1. GFR, Glomerular filtration rate; MELD, Model of end stage liver disease; CAD, Coronary artery disease.
  2. 1Flouroquinolones - 19, Selective serotonin re-uptake inhibitors - 10, Quinine - 6, Prepulside - 1.
  3. 2Q wave, T wave inversion and/or ST-depression (17, 18).